Found: 419
Select item for more details and to access through your institution.
Genetic variants of ABCB1 and CES1 genes on dabigatran metabolism in the Kazakh population.
- Published in:
- Caspian Journal of Internal Medicine, 2024, v. 15, n. 3, p. 499, doi. 10.22088/cjim.15.3.499
- By:
- Publication type:
- Article
Role of CES1 and ABCB1 Genetic Polymorphisms on Functional Response to Dabigatran in Patients with Atrial Fibrillation.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 9, p. 2545, doi. 10.3390/jcm13092545
- By:
- Publication type:
- Article
Assessing the relative contribution of CYP3A-and P-gp-mediated pathways to the overall disposition and drug-drug interaction of dabigatran etexilate using a comprehensive mechanistic physiological-based pharmacokinetic model.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1356273
- By:
- Publication type:
- Article
Factor XI Inhibitors: A New Horizon in Anticoagulation Therapy.
- Published in:
- Cardiology & Therapy, 2024, v. 13, n. 1, p. 1, doi. 10.1007/s40119-024-00352-x
- By:
- Publication type:
- Article
Drug–Drug Interactions of FXI Inhibitors: Clinical Relevance.
- Published in:
- Hematology Reports, 2024, v. 16, n. 1, p. 151, doi. 10.3390/hematolrep16010016
- By:
- Publication type:
- Article
Development of a Rapid Qualitative Screen for Anticoagulant Presence.
- Published in:
- Journal of Applied Laboratory Medicine, 2024, v. 9, n. 2, p. 305, doi. 10.1093/jalm/jfad081
- By:
- Publication type:
- Article
Andexanet alfa for reversal of direct factor Xa inhibitor anticoagulation.
- Published in:
- Australian Prescriber, 2024, v. 47, n. 1, p. 31, doi. 10.18773/austprescr.2024.008
- Publication type:
- Article
The impact of sodium‐glucose co‐transporter‐2 inhibitors on dementia and cardiovascular events in diabetic patients with atrial fibrillation.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2024, v. 40, n. 2, p. 1, doi. 10.1002/dmrr.3775
- By:
- Publication type:
- Article
A review on increasing risk for gastrointestinal bleeding associated with dabigatran.
- Published in:
- Signa Vitae, 2024, v. 20, n. 2, p. 13, doi. 10.22514/sv.2024.014
- By:
- Publication type:
- Article
Idarucizumab for Emergency Reversal of the Anticoagulant Effects of Dabigatran: Final Results of a Japanese Postmarketing Surveillance Study.
- Published in:
- Cardiology & Therapy, 2023, v. 12, n. 4, p. 723, doi. 10.1007/s40119-023-00333-6
- By:
- Publication type:
- Article
Prevention of dabigatran ınduced cytotoxicity by N-acetyl cysteine: An ın vitro study.
- Published in:
- Indian Journal of Experimental Biology, 2023, v. 61, n. 12, p. 946, doi. 10.56042/ijeb.v61i12.2738
- By:
- Publication type:
- Article
Early or late initiation of dabigatran versus vitamin-K-antagonists in acute ischemic stroke or TIA: The PRODAST study.
- Published in:
- International Journal of Stroke, 2023, v. 18, n. 10, p. 1169, doi. 10.1177/17474930231184366
- By:
- Publication type:
- Article
Budget and health impact of switching eligible patients with atrial fibrillation to lower-dose dabigatran.
- Published in:
- Journal of Market Access & Health Policy, 2023, v. 11, n. 1, p. 1, doi. 10.1080/20016689.2023.2247719
- By:
- Publication type:
- Article
Effects of nirmatrelvir/ritonavir on midazolam and dabigatran pharmacokinetics in healthy participants.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 11, p. 3352, doi. 10.1111/bcp.15835
- By:
- Publication type:
- Article
Novel Substituted Azoloazines with Anticoagulant Activity.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 21, p. 15581, doi. 10.3390/ijms242115581
- By:
- Publication type:
- Article
Reversing dabigatran effect with idarucizumab to enable intravenous thrombolysis in patients with acute ischaemic stroke -- a single centre experience.
- Published in:
- Polish Journal of Neurology & Neurosurgery / Neurologia i Neurochirurgia Polska, 2023, v. 57, n. 6, p. 465, doi. 10.5603/pjnns.96469
- By:
- Publication type:
- Article
Predicting Treatment Effects of a New‐to‐Market Drug in Clinical Practice Based on Phase III Randomized Trial Results.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 853, doi. 10.1002/cpt.2983
- By:
- Publication type:
- Article
Limitace účinnosti idarucizumabu při akutním renálním selhání -- kazuistika.
- Published in:
- Farmacie Pro Praxi, 2023, v. 19, n. 3, p. 173
- By:
- Publication type:
- Article
Suspected Rivaroxaban-Induced Anaphylaxis Secondary to Ingestion of Rivaroxaban and Nimesulide Without Cross-Reactivity to Dabigatran – A Case Report.
- Published in:
- Journal of Asthma & Allergy, 2023, v. 16, p. 1133, doi. 10.2147/JAA.S413057
- By:
- Publication type:
- Article
Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis.
- Published in:
- BMC Gastroenterology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12876-023-02960-8
- By:
- Publication type:
- Article
基于美国 FAERS 数据库的 3 种新型口服抗凝血药的 风险信号挖掘<sup>Δ</sup>.
- Published in:
- Evaluation & Analysis of Drug-Use in Hospitals of China, 2023, v. 23, n. 9, p. 1016, doi. 10.14009/j.issn.1672-2124.2023.08.027
- By:
- Publication type:
- Article
Efficacy and Safety of Oral Factor XIa Inhibitors in Stroke Prevention: A Systematic Review and Meta-Analysis.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 17, p. 5562, doi. 10.3390/jcm12175562
- By:
- Publication type:
- Article
2023 AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older People: A Summary of the Updates.
- Published in:
- Senior Care Pharmacist, 2023, v. 38, n. 9, p. 352, doi. 10.4140/TCP.n.2023.352
- By:
- Publication type:
- Article
Outcome after intracranial hemorrhage under dabigatran and reversal with idarucizumab versus under vitamin-K-antagonists - the RIC-ICH study.
- Published in:
- Frontiers in Neurology, 2023, p. 1, doi. 10.3389/fneur.2023.1212495
- By:
- Publication type:
- Article
In DVT, oral DTIs and factor Xa inhibitors reduce major bleeding but not recurrent VTE vs. conventional anticoagulants.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 8, p. JC92, doi. 10.7326/J23-0053
- By:
- Publication type:
- Article
Dabigatran Dosing Proposal for Adults With Atrial Fibrillation: Stress‐Testing Renal Function Range in Real World Patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 362, doi. 10.1002/cpt.2902
- By:
- Publication type:
- Article
Therapeutic Potential of Seaweed-Derived Laminaran: Attenuation of Clinical Drug Cytotoxicity and Reactive Oxygen Species Scavenging.
- Published in:
- Antioxidants, 2023, v. 12, n. 7, p. 1328, doi. 10.3390/antiox12071328
- By:
- Publication type:
- Article
Risk Profiles of New Users of Oral Anticoagulants Between 2011 and 2019 in Germany.
- Published in:
- Clinical Epidemiology, 2023, v. 15, p. 827, doi. 10.2147/CLEP.S405585
- By:
- Publication type:
- Article
Effect of direct oral anticoagulant dabigatran on early bone healing: An experimental study in rats.
- Published in:
- Journal of Advanced Periodontology & Implant Dentistry, 2023, v. 15, n. 2, p. 86, doi. 10.34172/japid.2023.020
- By:
- Publication type:
- Article
Electrochemical Disposable Biosensor to Monitor Dabigatran in Point-of-Care Anticoagulation Therapy.
- Published in:
- Molecules, 2023, v. 28, n. 13, p. 4953, doi. 10.3390/molecules28134953
- By:
- Publication type:
- Article
The efficacy of direct oral anticoagulants in patients on concomitant treatment with levetiracetam.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-33876-8
- By:
- Publication type:
- Article
Reversal agents for current and forthcoming direct oral anticoagulants.
- Published in:
- European Heart Journal, 2023, v. 44, n. 20, p. 1795, doi. 10.1093/eurheartj/ehad123
- By:
- Publication type:
- Article
Direct oral anticoagulants should often be suspended for longer before neuraxial blockade.
- Published in:
- Acta Anaesthesiologica Scandinavica, 2023, v. 67, n. 5, p. 682, doi. 10.1111/aas.14209
- By:
- Publication type:
- Article
Effectiveness and Safety of Dabigatran Reversal with Idarucizumab in the Taiwanese Population: A Comparison Based on Eligibility for Inclusion in Clinical Trials.
- Published in:
- Medicina (1010660X), 2023, v. 59, n. 5, p. 881, doi. 10.3390/medicina59050881
- By:
- Publication type:
- Article
An update on applications and limitations of direct oral anticoagulants.
- Published in:
- Egyptian Journal of Internal Medicine, 2023, v. 35, n. 1, p. 1, doi. 10.1186/s43162-023-00212-5
- By:
- Publication type:
- Article
Insights into the Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants in Older Adults with Atrial Fibrillation: A Structured Narrative Review.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 3, p. 351, doi. 10.1007/s40262-023-01222-w
- By:
- Publication type:
- Article
Investigation of Solid-State Hydrate-Anhydrous Phase Transformations of Dabigatran Etexilate Hemi-Edisylate.
- Published in:
- Crystals (2073-4352), 2023, v. 13, n. 3, p. 424, doi. 10.3390/cryst13030424
- By:
- Publication type:
- Article
Effects of Simvastatin on Pharmacokinetics and Anticoagulant Effects of Dabigatran in Healthy Subjects.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 3, p. 364, doi. 10.3390/ph16030364
- By:
- Publication type:
- Article
Factor Xa inhibitors versus vitamin K antagonist in morbidly obese patients with venous thromboembolism: a systematic review and meta-analysis.
- Published in:
- BMC Cardiovascular Disorders, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12872-023-03067-4
- By:
- Publication type:
- Article
Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1125576
- By:
- Publication type:
- Article
Peri-Interventional Triple Therapy with Dabigatran Modifies Vasomotion after Bare-Metal Stent Implantation in a Pig Coronary Artery Model.
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 2, p. 280, doi. 10.3390/jpm13020280
- By:
- Publication type:
- Article
Is a Lower Dose of Rivaroxaban Required for Asians? A Systematic Review of a Population Pharmacokinetics and Pharmacodynamics Analysis of Rivaroxaban.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 2, p. 588, doi. 10.3390/pharmaceutics15020588
- By:
- Publication type:
- Article
Factor XI inhibitors: cardiovascular perspectives.
- Published in:
- European Heart Journal, 2023, v. 44, n. 4, p. 280, doi. 10.1093/eurheartj/ehac464
- By:
- Publication type:
- Article
Correction: Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 1, p. 144, doi. 10.7326/L22-0482
- Publication type:
- Article
A new model to predict the risk of major gastrointestinal bleeding in patients on direct oral anticoagulants (dabigatran and rivaroxaban).
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 1, p. 253, doi. 10.1111/bcp.15491
- By:
- Publication type:
- Article
Factor XIa inhibition in atrial fibrillation: insights and knowledge gaps emerging from the PACIFIC-AF trial.
- Published in:
- Cardiovascular Research, 2023, v. 119, n. 1, p. e111, doi. 10.1093/cvr/cvac196
- By:
- Publication type:
- Article
Comparison of the DOAC Dipstick Test on Urine Samples With Chromogenic Substrate Methods on Plasma Samples in Outpatients Treated With Direct Oral Anticoagulants.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2023, v. 29, p. 1, doi. 10.1177/10760296231179684
- By:
- Publication type:
- Article
Minimizing drug-drug interactions between dabigatran and levetiracetam through clinical management: a case report.
- Published in:
- European Heart Journal Case Reports, 2023, v. 7, n. 1, p. 1, doi. 10.1093/ehjcr/ytad006
- By:
- Publication type:
- Article
Dabigatran: Clinical correlation of drug and its dose with risk of stroke and bleeding.
- Published in:
- Perspectives in Clinical Research, 2023, v. 14, n. 1, p. 26, doi. 10.4103/picr.picr_171_21
- By:
- Publication type:
- Article
Bleeding and risk for future cardiovascular events in patients with atrial fibrillation on oral anticoagulation: major bleeding is a major problem.
- Published in:
- European Heart Journal, 2022, v. 43, n. 47, p. 4909, doi. 10.1093/eurheartj/ehac627
- By:
- Publication type:
- Article